Evidence map›Paper›PMID 41295503›Full record

ArticleVaccines2025

Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized Mouse Models.

Jose D Gonzalez, Saleemulla Mahammad, Senay Beraki, Ariel Rodriguez-Frandsen, Neha Sheik, Elango Kathirvel, Francois Binette, David Weinstein, Anahid Jewett, Lu Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jose D GonzalezRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.ORCID 0009-0003-7389-2986
Saleemulla MahammadRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
Senay BerakiRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
Ariel Rodriguez-FrandsenRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
Neha SheikRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.ORCID 0009-0000-9256-8768
Elango KathirvelRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
Francois BinetteRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
David WeinsteinRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.
Anahid JewettDivision of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, Los Angeles School of Dentistry, University of California, 10833 Le Conte Ave, Los Angeles, CA 90095, USA.
Lu ChenRenovaro Biosciences, 2080 Century Park East, Suite 906, Los Angeles, CA 90067, USA.

Funding

Renovaro Biosciences RB-0012022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allogeneic engineered DCsCD40LCD93CXCL13DC therapyhematopoietic stem cellshumanized mouse modelsin vivo live imagingpancreatic cancervector optimization

Identifiers

PMID41295503
PMCPMC12656616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.